The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 14, 2016

Filed:

Sep. 19, 2013
Applicants:

Douglas V. Faller, Weston, MA (US);

Robert M. Williams, Fort Collins, CO (US);

Inventors:

Douglas V. Faller, Weston, MA (US);

Robert M. Williams, Fort Collins, CO (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 209/86 (2006.01); C07D 405/06 (2006.01); A61K 31/404 (2006.01); A61K 31/403 (2006.01); C07D 487/14 (2006.01); A61K 45/06 (2006.01); A61K 31/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/404 (2013.01); A61K 31/403 (2013.01); A61K 45/06 (2013.01); C07D 209/86 (2013.01); C07D 405/06 (2013.01); C07D 487/14 (2013.01);
Abstract

The invention is directed to compounds that are specific inhibitors of PKC delta, and methods and compositions for the treatment and prevention of cancers and other disorders. Compositions comprising compounds of the invention are used to treat cancers such as, for example, carcinoid and neuroendocrine tumors, malignant melanomas, pancreatic, gastrointestinal and lung cancers. Neuroendocrine tumor cell lines of pulmonary and gastrointestinal origin are surprisingly sensitive to PKC delta inhibition by the compounds of the invention. The invention is further directed to methods, compositions and kits containing compounds of the formulas (Ia), (IIa), (IIIa), (IVa), and (V) as disclosed and described in FIGS.and


Find Patent Forward Citations

Loading…